NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: CA2
NIH Registration Number: 0138
NIH Approval Number: NIHhESC-11-0138
Available for Distribution: Yes
Provider Restrictions: An MTA must be signed between the requesting investigator and Mount Sinai Hospital, Toronto Canada. A research plan is required and all research must have obtained relevant permissions through the requesting investigator's national regulations. In Canada, research must follow the Stem Cell Oversight Committee guidelines and SCOC approval for the use of the cell lines must be obtained.

Additional Information: (None)
NIH Restrictions: NIH-funded research with this line may only be conducted at Mount Sinai Hospital and “other Canadian laboratories affiliated with the Canadian Stem Cell Network for further research or potential clinical use."

Submitting Organization: Mt Sinai Hosp-Samuel Lunenfeld Research Institute
Provider Name: Andras Nagy
Provider Phone: 416 586-4800 x 3246
Provider Email:
Provider URL:
Approval Date: 12/12/2011

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:

  • (Emails that are offensive or unrelated to stem cells will be deleted.)

This page last updated on August 24, 2019 
Content Manager: 
Technical Issues: E-mail OER Webmaster